Royalty Pharma (RPRX) Financial Ratios: P/E, ROE & More

Royalty Pharma (RPRX) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Royalty Pharma had a P/E ratio of 21.41 (up from 13.20), return on equity of 13.2% (up from 13.0%), debt-to-equity of 0.92 (up from 0.74) and a current ratio of 2.40 (up from 1.44). A current ratio of 2.40 means current assets exceed current liabilities. Its dividend yield was 2.29% with a payout ratio of 49.1%.

Royalty Pharma Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Valuation Ratios
P/E Ratio	21.41	13.20	11.01	407.00	27.62	39.23
Forward P/E	7.70	6.09	7.47	10.32	13.00	19.16
P/S Ratio	6.94	5.01	5.31	7.79	7.48	9.15
P/B Ratio	1.70	1.10	1.24	1.83	1.67	1.96
Price/Tangible Book	2.97	1.63	1.92	3.10	2.97	4.05
Price/OCF	6.63	4.09	4.18	8.13	8.48	9.55
PEG Ratio	0.79	2.14	2.65	0.94	1.12	1.97
Enterprise Value Ratios
EV/Revenue	11.66	9.42	8.97	12.22	11.66	13.39
EV/EBITDA	17.73	-	14.11	29.44	18.36	16.88
EV/EBIT	17.78	16.50	14.16	29.62	18.65	17.11
Profitability & Returns
Return on Equity (ROE)	13.20%	13.03%	17.34%	2.33%	12.32%	21.23%
Return on Assets (ROA)	5.15%	4.67%	5.62%	3.36%	5.33%	7.29%
Return on Capital Employed (ROCE)	8.20%	7.60%	9.20%	5.90%	8.20%	10.60%
Leverage & Solvency Ratios
Debt/Equity	0.92	0.74	0.61	0.75	0.69	0.59
Debt/EBITDA	5.74	-	4.10	7.66	4.88	3.46
Liquidity Ratios
Current Ratio	2.40	1.44	7.90	2.19	16.81	8.76
Quick Ratio	2.39	1.43	7.78	2.11	16.77	8.73
Efficiency Ratios
Asset Turnover	0.13	0.13	0.14	0.13	0.14	0.15
Yield & Distribution Ratios
Earnings Yield	4.67%	7.58%	9.08%	0.25%	3.62%	5.02%
Dividend Yield	2.29%	3.31%	2.86%	1.93%	1.72%	0.67%
Payout Ratio	49.06%	43.83%	31.57%	778.21%	46.02%	40.80%
Buyback Yield	4.99%	1.46%	-37.66%	-5.59%	-10.48%	-
Total Return	7.28%	4.76%	-34.80%	-3.65%	-8.76%	0.67%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Royalty Pharma Financial Ratios

What is Royalty Pharma's P/E ratio?

Royalty Pharma's P/E ratio was 21.41 for fiscal 2025 (period ended Dec 31, 2025). It was 13.20 a year earlier.

What is Royalty Pharma's return on equity?

Royalty Pharma's return on equity (ROE) was 13.2% for fiscal 2025 (period ended Dec 31, 2025). It was 13.0% a year earlier.

What is Royalty Pharma's debt-to-equity ratio?

Royalty Pharma's debt-to-equity ratio was 0.92 for fiscal 2025 (period ended Dec 31, 2025). It was 0.74 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition